KURA ONCOLOGY, INC. (KURA) Operating cash flow 2016–2025
KURA ONCOLOGY, INC. (KURA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$64.1MFY2025 · since FY2016: -$25.3M → -$64.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$64.1M | -147.7% |
| FY2024 | $134.3M | +207.6% |
| FY2023 | -$124.8M | -13.4% |
| FY2022 | -$110.1M | -5.3% |
| FY2021 | -$104.6M | -49.7% |
| FY2020 | -$69.8M | -27.5% |
| FY2019 | -$54.8M | -12.5% |
| FY2018 | -$48.7M | -71.1% |
| FY2017 | -$28.4M | -12.2% |
| FY2016 | -$25.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KURA financial trends
KURA RevenueKURA Net incomeKURA Net marginKURA Gross profitKURA Gross marginKURA Operating incomeKURA Operating marginKURA Free cash flowKURA Capital expendituresKURA Return on equityKURA Stock buybacksKURA Dividends paidKURA Total assetsKURA Total liabilitiesKURA Shareholders’ equityKURA overview →